Clinical Trial Update: Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of steroids in Relapsing Remitting Multiple Sclerosis patients treated with glatiramer acetate; the study was terminated and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2014-01-06